Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system

Lignende værker

• Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System
  af: delMoral-Sanchez, Jose-Manuel, et al.
  Udgivet: (2019)
• Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
  af: delMoral-Sanchez, Jose-Manuel, et al.
  Udgivet: (2020)
• The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
  af: Tsume, Yasuhiro, et al.
  Udgivet: (2014)
• Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development
  af: Wolk, Omri, et al.
  Udgivet: (2014)
• Global testing of a consensus solubility assessment to enhance robustness of the WHO biopharmaceutical classification system
  af: Valeria Gigante, et al.
  Udgivet: (2020-10-01)